Chemotherapy plus radiotherapy makes curability a possibility in nasopharyngeal carcinoma patients with distant metastasis at diagnosis

Head and Neck Oncology

Volumn 5, Issue 1, 2013, Pages

  Hui, Lin ^a   Huan Xin, Lin ^a   Xiu Yu, Cai ^a   Ting, Jin ^b   Guo, Li Bing ^c   Hong Zhi, Wang ^a   Rui, Sun ^a   Wei Han, Hu ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b ZHEJIANG CANCER HOSPITAL   (China)

^c GUANGDONG SECOND PROVINCIAL GENERAL HOSPITAL   (China)

Author keywords

Chemotherapy; Metastasis; Nasopharyngeal carcinoma; Prognostic; Radiotherapy

Indexed keywords

BLEOMYCIN; CISPLATIN; FLUOROURACIL; GEMCITABINE; PACLITAXEL;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL EFFECTIVENESS; CONTINUOUS INFUSION; CONTROLLED STUDY; DISTANT METASTASIS; DRUG EFFICACY; FEMALE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SURVIVAL RATE; SURVIVAL TIME;

EID: 84872711353     PISSN: None     EISSN: 17583284     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Yu, MC, Yuan, JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 2002;12:421-429. (Pubitemid 35370755)
2. Chang, ET, Adami, HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006;15:1765-1777. (Pubitemid 44664247)
3. Jemal, A, Bray, F, Center, MM, Ferlay, J, Ward, E, Forman, D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
4. Khor, TH, Tan, BC, Chua, EJ, Chia, KB. Distant metastases in nasopharyngeal carcinoma. Clin Radiol 1978;29:27-30. (Pubitemid 8253413)
5. Ahmad, A, Stefani, S. Distant metastases of nasopharyngeal carcinoma: a study of 256 male patients. J Surg Oncol 1986;33:194-197. (Pubitemid 17188823)
6. Teo, PM, Kwan, WH, Lee, WY, Leung, SF, Johnson, PJ. Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer 1996;77:2423-2431. (Pubitemid 26169137)
7. Sham, JS, Cheung, YK, Chan, FL, Choy, D. Nasopharyngeal carcinoma: pattern of skeletal metastases. Br J Radiol 1990;63:202-205. (Pubitemid 20107271)
8. Tan, EH, Khoo, KS, Wee, J, et al. Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma. Ann Oncol 1999;10:235-237. (Pubitemid 29113186)
9. Lee, AW, Lin, JC, Ng, WT. Current management of nasopharyngeal cancer. Semin Radiat Oncol 2012;22:233-244.
10. Ma, J, Mai, HQ, Hong, MH, et al. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol 2001;19:1350-1357. (Pubitemid 32202540)
11. Cvitkovic, E, Bachouchi, M, Boussen, H, et al. Leukemoid reaction, bone marrow invasion, fever of unknown origin, and metastatic pattern in the natural history of advanced undifferentiated carcinoma of nasopharyngeal type: a review of 255 consecutive cases. J Clin Oncol 1993;11:2434-2442. (Pubitemid 23353975)
12. Ahmad, A, Stefani, S. Distant metastases of nasopharyngeal carcinoma: a study of 256 male patients. J Surg Oncol 1986;33:194-197. (Pubitemid 17188823)
13. Chua, ML, Ong, SC, Wee, JT, et al. Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma. Head Neck 2009;31:346-354.
14. Boussen, H, Cvitkovic, E, Wendling, JL, et al. Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil. J Clin Oncol 1991;9:1675-1681.
15. Ong, YK, Heng, DM, Chung, B, et al. Design of a prognostic index score for metastatic nasopharyngeal carcinoma. Eur J Cancer 2003;39:1535-1541. (Pubitemid 36829194)
16. Jin, Y, Cai, XY, Shi, YX, et al. Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma. J Cancer Res Clin Oncol 2012.
17. Dos, SL, Lima, JP, Lima, CS, Sasse, EC, Sasse, AD. Is there a role for consolidative radiotherapy in the treatment of aggressive and localized Non-Hodgkin Lymphoma? A systematic review with meta-analysis. Bmc Cancer 2012;12:288.
18. Lee, AW, Poon, YF, Foo, W, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 1992;23:261-270.
19. Teo, PM, Kwan, WH, Lee, WY, Leung, SF, Johnson, PJ. Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer 1996;77:2423-2431. (Pubitemid 26169137)
20. Posner, MR, Hershock, DM, Blajman, CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007;357:1705-1715. (Pubitemid 350005152)
21. Vermorken, JB, Remenar, E, van Herpen, C, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 2007;357:1695-1704. (Pubitemid 350005151)
22. Cohen, EEW, Karrison, T, Kocherginsky, M, et al. DeCIDE: A phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN). ASCO Meeting Abstracts 2012;30:5500.